XML 22 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Add'l Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Unearned ESOP
Treasury Stock
Noncontrolling Interests
Beginning balance at Dec. 31, 2014 $ 23,354,000 $ 4,000,000 $ 3,107,000 $ 4,846,000 $ 23,045,000 $ (8,017,000) $ (325,000) $ (4,233,000) $ 931,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net Income available for The Dow Chemical Company common stockholder 7,345,000       7,345,000        
Other comprehensive income (loss) (650,000)         (650,000)      
Dividends to stockholders (1,942,000)       (1,942,000)        
Common stock issued / sold 1,274,000     508,000       766,000  
Stock-based compensation and allocation of ESOP shares (376,000)     (429,000)     53,000    
Impact of noncontrolling interests (122,000)               (122,000)
Treasury stock purchases (2,688,000)             (2,688,000)  
Other (12,000)     11,000 (23,000)        
Ending balance at Dec. 31, 2015 26,183,000 4,000,000 3,107,000 4,936,000 28,425,000 (8,667,000) (272,000) (6,155,000) 809,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net Income available for The Dow Chemical Company common stockholder 3,978,000       3,978,000        
Other comprehensive income (loss) (1,155,000)         (1,155,000)      
Dividends to stockholders (2,037,000)       (2,037,000)        
Common stock issued / sold 1,115,000     398,000       717,000  
Stock-based compensation and allocation of ESOP shares (325,000)     (376,000)     51,000    
ESOP shares acquired (18,000)           (18,000)    
Impact of noncontrolling interests 433,000               433,000
Treasury stock purchases (916,000)             (916,000)  
Preferred stock converted to common stock 0 (4,000,000)   695,000       4,695,000  
Other (29,000)     (1,000) (28,000)        
Ending balance at Dec. 31, 2016 27,229,000 0 3,107,000 4,262,000 30,338,000 (9,822,000) (239,000) (1,659,000) 1,242,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net Income available for The Dow Chemical Company common stockholder 466,000       466,000        
Other comprehensive income (loss) 1,231,000         1,231,000      
Dividends to stockholders (1,673,000)       (1,673,000)        
Dividends to parent (1,056,000)       (1,056,000)        
Common stock issued / sold 1,147,000     423,000       724,000  
Issuance of parent company stock 66,000     66,000          
Stock-based compensation and allocation of ESOP shares (318,000)     (368,000)     50,000    
Impact of noncontrolling interests (56,000)               (56,000)
Merger impact 0   3,107,000 2,172,000       935,000  
Other (27,000)     (2,000) (25,000)        
Ending balance at Dec. 31, 2017 $ 27,009,000 $ 0 $ 0 $ 6,553,000 $ 28,050,000 $ (8,591,000) $ (189,000) $ 0 $ 1,186,000